Increase efficiencies and productivity by automating core reporting tasks for medical writing.
Automate core regulatory report documents across the CTD pyramid and dramatically accelerate submission timelines.
Yseop’s first CMC-focused offering automates the Quality Overall Summary (Module 2.3), a central component of regulatory submissions that pulls structured insights from Module 3.2.
Yseop Expands into CMC: Redefining Regulatory Automation Beyond Clinical Read More »
The FDA has begun using generative AI to review drug submissions, signaling a major shift in regulatory review. Learn how this impacts pharma teams and what it takes to make your content AI-ready.
The AI landscape is evolving rapidly. While pre-configured workflows have powered automation for years, the next frontier lies in intelligent AI agents—systems that can plan, adapt and execute tasks dynamically rather than following static scripts.
From Workflows to AI Agents: The Next Evolution in Automation Read More »
Yseop’s latest whitepaper, “Harness the Power of Generative AI in Pharma,” is now live! Discover how Generative AI is transforming drug discovery, accelerating clinical trials, and streamlining regulatory submissions. Download now.
Strategic Choices for AI in Biopharma: Partnering for Effective Implementation Read More »